Molecular Mechanisms and Metabolomics of Natural Polyphenols Interfering with Breast Cancer Metastasis

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2016 Dec 22

PMID 27999314

Citations 18

Authors

Yingqian Ci

Jinping Qiao

Mei Han

Affiliations

Soon will be listed here.

Abstract

Metastatic cancers are the main cause of cancer-related death. In breast primary cancer, the five-year survival rate is close to 100%; however, for metastatic breast cancer, that rate drops to a mere 25%, due in part to the paucity of effective therapeutic options for treating metastases. Several in vitro and in vivo studies have indicated that consumption of natural polyphenols significantly reduces the risk of cancer metastasis. Therefore, this review summarizes the research findings involving the molecular mechanisms and metabolomics of natural polyphenols and how they may be blocking breast cancer metastasis. Most natural polyphenols are thought to impair breast cancer metastasis through downregulation of MMPs expression, interference with the VEGF signaling pathway, modulation of EMT regulator, inhibition of NF-κB and mTOR expression, and other related mechanisms. Intake of natural polyphenols has been shown to impact endogenous metabolites and complex biological metabolic pathways in vivo. Breast cancer metastasis is a complicated process in which each step is modulated by a complex network of signaling pathways. We hope that by detailing the reported interactions between breast cancer metastasis and natural polyphenols, more attention will be directed to these promising candidates as effective adjunct therapies against metastatic breast cancer in the clinic.

Citing Articles

Biological Activities of Molecules Derived from L. Tested .

Marrone G, Urciuoli S, Candi E, Bernini R, Vanni G, Masci C Life (Basel). 2024; 14(1).

PMID: 38255664 PMC: 10820526. DOI: 10.3390/life14010049.

Notch3 restricts metastasis of breast cancers through regulation of the JAK/STAT5A signaling pathway.

Chen M, Fang Z, Wu Z, Bai J, Li R, Wen X BMC Cancer. 2023; 23(1):1257.

PMID: 38124049 PMC: 10734157. DOI: 10.1186/s12885-023-11746-w.

Co-administration of Chrysin and Luteolin with Cisplatin and Topotecan Exhibits a Variable Therapeutic Value in Human Cancer Cells, HeLa.

Raina R, Hussain A, Almutary A, Haque S, Raza T, DSouza A ACS Omega. 2023; 8(44):41204-41213.

PMID: 37970041 PMC: 10633856. DOI: 10.1021/acsomega.3c04443.

Antitumor Effects of Microencapsulated Extract on Breast Carcinoma and Human Cervical Cancer Cells In Vitro.

Navolokin N, Lomova M, Bucharskaya A, Godage O, Polukonova N, Shirokov A Materials (Basel). 2023; 16(4).

PMID: 36837099 PMC: 9960207. DOI: 10.3390/ma16041470.

Phytochemicals as Chemo-Preventive Agents and Signaling Molecule Modulators: Current Role in Cancer Therapeutics and Inflammation.

Ahmed M, Islam S, Alghamdi A, Kamran M, Ahsan H, Lee Y Int J Mol Sci. 2022; 23(24).

PMID: 36555406 PMC: 9779495. DOI: 10.3390/ijms232415765.

References

So F, Guthrie N, Chambers A, Carroll K . Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett. 1997; 112(2):127-33. DOI: 10.1016/s0304-3835(96)04557-0. View

Zhou H, Huang S . mTOR signaling in cancer cell motility and tumor metastasis. Crit Rev Eukaryot Gene Expr. 2010; 20(1):1-16. PMC: 2883790. DOI: 10.1615/critreveukargeneexpr.v20.i1.10. View

Vantyghem S, Wilson S, Postenka C, Al-Katib W, Tuck A, Chambers A . Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model. Cancer Res. 2005; 65(8):3396-403. DOI: 10.1158/0008-5472.CAN-04-4109. View

WALKER E, Pacold M, Perisic O, Stephens L, Hawkins P, Wymann M . Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell. 2000; 6(4):909-19. DOI: 10.1016/s1097-2765(05)00089-4. View

Bahar M, Khaghani S, Pasalar P, Paknejad M, Khorramizadeh M, Mirmiranpour H . Exogenous coenzyme Q10 modulates MMP-2 activity in MCF-7 cell line as a breast cancer cellular model. Nutr J. 2010; 9:62. PMC: 3004807. DOI: 10.1186/1475-2891-9-62. View

Wishart D . Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016; 15(7):473-84. DOI: 10.1038/nrd.2016.32. View

Kusano M, Yang Z, Okazaki Y, Nakabayashi R, Fukushima A, Saito K . Using metabolomic approaches to explore chemical diversity in rice. Mol Plant. 2015; 8(1):58-67. DOI: 10.1016/j.molp.2014.11.010. View

Loffek S, Schilling O, Franzke C . Series "matrix metalloproteinases in lung health and disease": Biological role of matrix metalloproteinases: a critical balance. Eur Respir J. 2010; 38(1):191-208. DOI: 10.1183/09031936.00146510. View

Mylona E, Magkou C, Giannopoulou I, Agrogiannis G, Markaki S, Keramopoulos A . Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome. Breast Cancer Res. 2006; 8(5):R57. PMC: 1779495. DOI: 10.1186/bcr1607. View

10.

Solanky K, Bailey N, Holmes E, Lindon J, Davis A, Mulder T . NMR-based metabonomic studies on the biochemical effects of epicatechin in the rat. J Agric Food Chem. 2003; 51(14):4139-45. DOI: 10.1021/jf025677f. View

11.

Zhang J, Guan J, Yang F, Liu H, Cheng X, Li S . Qualitative and quantitative analysis of four species of Curcuma rhizomes using twice development thin layer chromatography. J Pharm Biomed Anal. 2008; 48(3):1024-8. DOI: 10.1016/j.jpba.2008.07.006. View

12.

Mileo A, Di Venere D, Linsalata V, Fraioli R, Miccadei S . Artichoke polyphenols induce apoptosis and decrease the invasive potential of the human breast cancer cell line MDA-MB231. J Cell Physiol. 2011; 227(9):3301-9. DOI: 10.1002/jcp.24029. View

13.

Gallardo M, Calaf G . Curcumin inhibits invasive capabilities through epithelial mesenchymal transition in breast cancer cell lines. Int J Oncol. 2016; 49(3):1019-27. DOI: 10.3892/ijo.2016.3598. View

14.

Manach C, Scalbert A, Morand C, Remesy C, Jimenez L . Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004; 79(5):727-47. DOI: 10.1093/ajcn/79.5.727. View

15.

Huber M, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H . NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest. 2004; 114(4):569-81. PMC: 503772. DOI: 10.1172/JCI21358. View

16.

Magalhaes P, Carvalho D, Cruz J, Guido L, Barros A . Fundamentals and health benefits of xanthohumol, a natural product derived from hops and beer. Nat Prod Commun. 2009; 4(5):591-610. View

17.

Kronski E, Fiori M, Barbieri O, Astigiano S, Mirisola V, Killian P . miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2. Mol Oncol. 2014; 8(3):581-95. PMC: 5528633. DOI: 10.1016/j.molonc.2014.01.005. View

18.

Gallardo M, Calaf G . Curcumin and epithelial-mesenchymal transition in breast cancer cells transformed by low doses of radiation and estrogen. Int J Oncol. 2016; 48(6):2534-42. DOI: 10.3892/ijo.2016.3477. View

19.

Lewandowska U, Szewczyk K, Owczarek K, Hrabec Z, Podsedek A, Sosnowska D . Procyanidins from evening primrose (Oenothera paradoxa) defatted seeds inhibit invasiveness of breast cancer cells and modulate the expression of selected genes involved in angiogenesis, metastasis, and apoptosis. Nutr Cancer. 2013; 65(8):1219-31. DOI: 10.1080/01635581.2013.830314. View

20.

Safavy A, Raisch K, Mantena S, Sanford L, Sham S, Krishna N . Design and development of water-soluble curcumin conjugates as potential anticancer agents. J Med Chem. 2007; 50(24):6284-8. DOI: 10.1021/jm700988f. View